Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ethics committees. Separate criteria should be drawn up for questionnaire based epidemiological studies.

BMJ (Clinical research ed.)·1996
Same author

Accident experience and notification rates in people with recent seizures, epilepsy or undiagnosed episodes of loss of consciousness.

QJM : monthly journal of the Association of Physicians·1995
Same author

The effects of fasting on the thermogenic, metabolic and cardiovascular responses to infused adrenaline.

The British journal of nutrition·1995
Same author

HIV risk: no impact on medical student specialty choice.

Rhode Island medicine·1995
Same author

Control of neuronal morphology in vitro: interplay between adhesive substrate forces and molecular instruction.

Journal of neuroscience research·1995
Same author

Structure of the hepatic control region of the human apolipoprotein E/C-I gene locus.

The Journal of biological chemistry·1995
Same journal

Pityriasis lichenoides et varioliformis.

Proceedings of the Royal Society of Medicine·2010
Same journal

Hand-Schüller-Christian syndrome.

Proceedings of the Royal Society of Medicine·2010
Same journal

Lymphadenoma.

Proceedings of the Royal Society of Medicine·2010
Same journal

Cirrhosis and ascites (treated by omentopexy twelve years ago after investigation by thorium dioxide).

Proceedings of the Royal Society of Medicine·2010
Same journal

Suppurative arthritis of right elbow following mastoiditis.

Proceedings of the Royal Society of Medicine·2010
Same journal

Meningococcal meningitis with suppurative arthritis.

Proceedings of the Royal Society of Medicine·2010
See all related articles

Related Experiment Video

Updated: Jun 18, 2026

Immunolabelling Myofiber Degeneration in Muscle Biopsies
06:37

Immunolabelling Myofiber Degeneration in Muscle Biopsies

Published on: December 5, 2019

Myopathy

J Taylor

    Proceedings of the Royal Society of Medicine
    |December 9, 2009
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
    09:39

    Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

    Published on: July 29, 2016

    Related Experiment Videos

    Last Updated: Jun 18, 2026

    Immunolabelling Myofiber Degeneration in Muscle Biopsies
    06:37

    Immunolabelling Myofiber Degeneration in Muscle Biopsies

    Published on: December 5, 2019

    Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
    09:39

    Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

    Published on: July 29, 2016